Clinical Trials · NCT06817356
A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 308
- Start date
- Feb 2025
- Locations
- 25 sites, United States
- Primary endpoint
- Behaviors Associated with Alcohol Use Disorder (AUD) as Assessed by the Timeline Followback Method